Your browser doesn't support javascript.
loading
Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup.
Emons, Julius; Fasching, Peter A; Wunderle, Marius; Heindl, Felix; Rieger, Jens; Horn, Florian; Pelzer, Georg; Ritter, Andre; Weber, Thomas; Radicke, Marcus; Polifka, Iris; Wachter, David L; Wenkel, Evelyn; Michel, Thilo; Uder, Michael; Hartmann, Arndt; Anton, Gisela; Beckmann, Matthias W; Schulz-Wendtland, Rüdiger; Jud, Sebastian M.
Afiliación
  • Emons J; Department of Gynecology and Obstetrics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
  • Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, Erlangen 91054, Germany.
  • Wunderle M; Department of Gynecology and Obstetrics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
  • Heindl F; Department of Gynecology and Obstetrics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
  • Rieger J; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Horn F; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Pelzer G; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Ritter A; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Weber T; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Radicke M; Siemens Healthcare GmbH, Erlangen, Germany.
  • Polifka I; Institute of Pathology, Erlangen University Hospital, Erlangen, Germany.
  • Wachter DL; Institute of Pathology, Erlangen University Hospital, Erlangen, Germany.
  • Wenkel E; Institute of Diagnostic Radiology, Erlangen University Hospital, Erlangen, Bayern, Germany.
  • Michel T; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Uder M; Institute of Diagnostic Radiology, Erlangen University Hospital, Erlangen, Bayern, Germany.
  • Hartmann A; Institute of Pathology, Erlangen University Hospital, Erlangen, Germany.
  • Anton G; Erlangen Center for Astroparticle Physics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Beckmann MW; Department of Gynecology and Obstetrics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
  • Schulz-Wendtland R; Institute of Diagnostic Radiology, Erlangen University Hospital, Erlangen, Bayern, Germany.
  • Jud SM; Department of Gynecology and Obstetrics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
Ther Adv Med Oncol ; 12: 1758835920957932, 2020.
Article en En | MEDLINE | ID: mdl-32994806
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania